You searched for "IOP"
Risk factors identified for glaucoma progression in paediatric glaucoma suspects
A retrospective case review was conducted of children (<18 years) identified as being glaucoma suspects using common clinical criteria or the Childhood Glaucoma Research Network definition. Exclusion criteria included penetrating ocular trauma, treated ocular hypertension / glaucoma and use of...Oral Ibuprofen reduces early bleb failure in high risk trabeculectomy
29 November 2024
| Su Young
|
EYE - Glaucoma
In this retrospective cohort study, 288 eyes of 273 patients (mean ±SD age: 68.56 ±10.47 y; 32.60% females) with primary glaucoma who underwent trabeculectomy / phacotrabeculectomy at the Singapore National Eye Centre between April 2020 and April 2021 with a...
Beyond ‘Shield and Ship’: a novel device (Eye-Aid) to provide temporary aqueous tamponade
4 February 2025
| Ben Smith
|
EYE - Cornea
The authors present a pilot efficacy study of the novel Eye-Aid device in a porcine model of full-thickness corneal wounds to mitigate anterior chamber collapse in the forward military environment. Currently, the ‘Shield and Ship’ paradigm taught to military healthcare...
A Multidisciplinary Approach to Neovascular Glaucoma in a Patient with Waldenström’s macroglobulinemia
1 December 2013
| Inderpaul S Sian, Karl Whittaker
An 84-year-old Caucasian male attended eye casualty with a four month history of reduced vision, a dull ache and photophobia in both eyes. He had also reported dizziness, weakness and intermittent epistaxis in the nine months prior to presentation. There...
Long-term outcome of ALPI for plateau iris syndrome
1 April 2018
| Chrysostomos D Dimitriou
|
EYE - Glaucoma
The purpose of this study was to evaluate the long-term outcomes of plateau iris syndrome (PIS) patients treated with argon laser peripheral iridoplasty (ALPI) following YAG laser peripheral iridotomy (LPI). Typical ALPI settings were a spot size of 200 to...
Intravitreal dexamethasone in diabetic macular oedema (DMO) - enhancing the response to anti-VEGF in non- or poor responders
3 February 2023
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Aflibercept, Anti-VEGF, Dexamethasone implant, Diabetic macular oedema, Persistent, Ranibizumab, Resistant
This study aimed to describe the outcomes of a switch back from DEXi (dexamethasone implant) to anti-VEGF therapy in eyes that were treated temporarily with DEXi after an initial poor response to anti VEGF. Twenty-three eyes of 17 patients were...
ROP and weight gain
The authors aimed to examine the relationship between postnatal weight gain and development of retinopathy of prematurity (ROP) among very preterm infants. They examined weight changes in the early postnatal period from birth to the first day of established full...Preterm birth and refractive error in an Indian infant population
This study was undertaken to identify and compare the changes in refractive outcome in infants with and without retinopathy of prematurity (ROP), to inform incidence of refractive error. This was a prospective study of 300 consecutive premature infants with birth...Diagnostic error rates for ROP detection by trainee ophthalmologists
The purpose of this study was to characterise common errors in ROP diagnosis by ophthalmologists-in-training in the USA and Canada. Case acquisition was from a web-based system used for ROP assessment from which 20 cases were selected. Fifty-five trainees from...Learnings and trends in the management of open-angle and angle-closure glaucoma
1 August 2017
| Winifred Nolan, Nick Strouthidis, Keith Barton
|
EYE - Glaucoma
To be truly disruptive, newer technologies need to offer a quality of life benefit over medication to a broad population of glaucoma sufferers. Evidence and converging trends in medical and surgical management of glaucoma were explored in counterpoint discussions and...